openPR Logo
Press release

Erectile Dysfunction Market to Witness Development of Innovative Device Therapy Solutions by 2023 |Arizton

Erectile dysfunction is one of the most common sexual health disorders, and it affects a significant portion of the male population.

A recent report by Arizton states that the high prevalence of ED and associated chronic conditions such as prostate cancer, benign prostate hyperplasia, diabetes, CVDs, which can, in turn, pose as a high-risk factor for the occurrence of this disease are factors driving the development of innovative drug and device therapy in the global market.

Increasing disease awareness, growing patient willingness to seek medical assistance for disease management, and the increasing presence of favorable healthcare guidelines will enable vendors to launch new treatment solutions in the global erectile dysfunction market. The recent emergent low-intensity extra-corporeal shockwave therapy holds the potential to deliver a permanent treatment solution to the disease during the forecast period.

The global erectile dysfunction market is estimated to generate revenues of over $4.5 billion by 2023.

Read the full report on Erectile Dysfunction Market – Global Outlook and Forecast 2018-2023
https://www.arizton.com/market-reports/erectile-dysfunction-market

The various device therapy available in the erectile dysfunction market are:

· Penile Implants

Penile implants are known as a penile prosthesis. These implants are the medical devices that are implanted into the penis through an outpatient surgical procedure. Penile implants were one of the initial therapies to be used for the treatment of erectile dysfunction. Penile implants are considered as an end-stage treatment option for ED.

Two broad types of penile implants are currently available in the market, and it consists of non-inflatable implants (3-piece and 2-piece) and non-inflatable or malleable implants. The leading vendors are focusing on introducing advances in penile prosthesis to make the implant more natural, durable, and reliable devices. The various prosthesis available in the market includes kink resistant tubing, rear tip extenders, lock-out valve, tactile pump, polypropylene cylinder coating, and antibiotic-impregnated devices. The key benefits of penile implants include potential to cure the disease permanently, end-therapy for an option for other therapy type non-responders, high patient satisfaction rates, and leads to a more natural erection. The key players are investing in the R&D for innovative, superior, and newer generation prosthesis with safer and high-efficacy profile as the demand for better quality products is the top priority for healthcare providers as well as patients.

· Vacuum Therapy Devices

Vacuum therapy devices use negative pressure to distend the corporal sinusoids and increase the blood inflow to the penis, thereby achieving penile erections. The device consists of a hollow tube, automated or manual pump, and constriction rings. Vacuum therapy devices may be classified as vacuum constriction device (VCD) and vacuum erectile device (VED). The VCD features an external constricting ring, which needs to be placed at the base of the penis to prevent blood outflow from the corpora cavernosa to maintain an erection. The VED uses the vacuum therapy without a constrictive ring, with the objective of increasing blood oxygenation in the corpora cavernosa. The use of VCDs are considered as one of a key non-invasive, effective, safe, drug-free and cost-effective erectile dysfunction treatment options, especially for PDE5 non-responders, and these devices are often used in penile rehabilitation programs. The increasing commercial availability of these vacuum therapy devices will boost the adoption of these devices and result in effective management of erectile dysfunction in the global market. The increase in a number of people seeking erectile dysfunction treatment, growth in e-commerce promotions and marketing of VCDs, and increase in disease awareness, high availability of OTC certified devices will propel the growth of the market during the forecast period.

· Others Erectile Dysfunction Devices

The discoveries and technological innovations through medical research is resulting in the expansion of treatment modalities for various diseases, especially erectile dysfunction. The top players are leveraging technology to introduce a wide range option in the global market such as external penile support devices, penile vibrators, and low-intensity extracorporeal shockwave devices. The use of low-intensity extracorporeal shockwave (LI-ESW) for the treatment of ED is one of highly research areas. The device is a new and noninvasive technique to modify the structures involved in developing an erection through the application of shockwaves to targeted sites along the penile shaft, which, in turn, causes reactions that result in neovascularization of the penile tissue. The product is approved for use in select countries such as Saudi Arabia, Brazil, Indonesia, Colombia, and Mexico.

The prominent players operating in the erectile dysfunction market are Bayer AG, Eli Lilly and Company, VIVUS, Inc, Pfizer, Boston Scientific Corp., and Coloplast A/S.

Order a report now: https://www.arizton.com/market-reports/erectile-dysfunction-market

Read: Erectile Dysfunction Market is Expected to Worth Over $4 Billion by 2023
https://www.arizton.com/news/press-release/erectile-dysfunction-market-size

Read: Erectile Dysfunction Devices Therapies Market to Worth Over $645 Million by 2023
https://www.arizton.com/news/press-release/erectile-dysfunction-devices-therapies-market

About Arizton
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Arizton Advisory & Intelligence
Chicago, IL
60605

Mail: enquiry@arizton.com

Call: +1-312-465-7864

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Erectile Dysfunction Market to Witness Development of Innovative Device Therapy Solutions by 2023 |Arizton here

News-ID: 1013832 • Views:

More Releases for Erectile

Erectile Dysfunction Drugs Market Beyond the Bedroom: The Impact of Erectile Dys …
Erectile Dysfunction Drugs Market to reach over USD XX billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Erectile Dysfunction Drugs Market Size, Share & Trends Analysis Report By Drug (Avanafil (Stendra), Muse Suppository (Alprostadil), Sildenafil (Viagra)), Mode of Administration (Injections, Oral, Topical), Distribution Channel (hospital pharmacies, online pharmacies, and retail pharmacies), Region, Market
Global Erectile Dysfunction Devices Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Erectile Dysfunction Devices Market is projected to grow at a CAGR of 9.6% from 2023 to 2028. The market is driven by the increasing prevalence of erectile dysfunction amongst young men, advancements in medical technology, growing awareness and acceptance, the aging population, and strategic collaborations. Browse 147 Market Data Tables and 115 Figures spread through 163 Pages
Erectile dysfunction drugs market to Surpass erectile dysfunction drugs market | …
Global Erectile Dysfunction Drugs Market size was valued at USD 2130 million in 2021 and is projected to reach USD 3250 million by 2028, growing at a CAGR of 5.4% from 2021 to 2028 according to a new report by Intellectual Market Insights Research. Get Sample Report:https://www.intellectualmarketinsights.com/download-sample/IMI-003946 Scope of Erectile Dysfunction Drugs Market Report: A recent market research report added to repository of Intellectual Market Insights Research is an in-depth analysis of Global
Global Erectile Dysfunction Devices Market Report
As per GME studies, on the Global Erectile Dysfunction Devices Market, it is analyzed that the market will grow at a CAGR of 6.5%. Erectile dysfunction incidence increases with growing age, about 5-10% of men under 40 years are the possible suspects for the dysfunctionality. This is projected to drive the ED device market in the coming years also. Raising the aforementioned disease prevalence and the growing percentage of tobacco
Erectile Dysfunction Drugs Market Size, Erectile Dysfunction Drugsmarket Share, …
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025. Request for Sample of This Research Report @ https://bit.ly/2NXzatD Top Key Players:- Bayer AG Pfizer Eli Lilly & Co. Vivus, Inc. S.K. Chemicals Co. Ltd. Dong-A Pharmaceutical Co. Ltd Meda Pharmaceuticals Apricus Biosciences Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying According to a new study published by Polaris Market Research the global erectile dysfunction
Erectile Dysfunction Market Industry Forecast till 2024
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a